These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38202282)

  • 1. Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Rohrhofer J; Hauser L; Lettenmaier L; Lutz L; Koidl L; Gentile SA; Ret D; Stingl M; Untersmayr E
    J Clin Med; 2024 Jan; 13(1):. PubMed ID: 38202282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.
    Twisk FN
    Front Physiol; 2014; 5():109. PubMed ID: 24734022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the mental health burden in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients in Switzerland: A pilot study.
    König RS; Paris DH; Sollberger M; Tschopp R
    Heliyon; 2024 Mar; 10(5):e27031. PubMed ID: 38434357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Vernon SD; Hartle M; Sullivan K; Bell J; Abbaszadeh S; Unutmaz D; Bateman L
    Work; 2023; 74(4):1179-1186. PubMed ID: 36911963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
    Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
    J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
    Maes M; Twisk FN; Johnson C
    Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: implications for disease-related biomarker discovery.
    Martín F; Blanco-Suárez M; Zambrano P; Cáceres O; Almirall M; Alegre-Martín J; Lobo B; González-Castro AM; Santos J; Domingo JC; Jurek J; Castro-Marrero J
    Front Immunol; 2023; 14():1253121. PubMed ID: 37744357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
    Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
    Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
    medRxiv; 2022 Jan; ():. PubMed ID: 35043127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    van Campen CLMC; Rowe PC; Verheugt FWA; Visser FC
    Front Med (Lausanne); 2020; 7():602894. PubMed ID: 33585505
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems in defining post-exertional malaise.
    Jason LA; Evans M; So S; Scott J; Brown A
    J Prev Interv Community; 2015; 43(1):20-31. PubMed ID: 25584525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evidence base for physiotherapy in myalgic encephalomyelitis/chronic fatigue syndrome when considering post-exertional malaise: a systematic review and narrative synthesis.
    Wormgoor MEA; Rodenburg SC
    J Transl Med; 2021 Jan; 19(1):1. PubMed ID: 33397399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and clinical factors associated with post-exertional malaise severity in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Ghali A; Richa P; Lacout C; Gury A; Beucher AB; Homedan C; Lavigne C; Urbanski G
    J Transl Med; 2020 Jun; 18(1):246. PubMed ID: 32571354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lutz L; Rohrhofer J; Zehetmayer S; Stingl M; Untersmayr E
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
    PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
    Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
    J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G; Maes M
    Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.